176 related articles for article (PubMed ID: 25399586)
1. A review of ELTD1, a pro-angiogenic adhesion GPCR.
Favara DM; Banham AH; Harris AL
Biochem Soc Trans; 2014 Dec; 42(6):1658-64. PubMed ID: 25399586
[TBL] [Abstract][Full Text] [Related]
2. ADGRL4/ELTD1 is a highly conserved angiogenesis-associated orphan adhesion GPCR that emerged with the first vertebrates and comprises 3 evolutionary variants.
Favara DM; Banham AH; Harris AL
BMC Evol Biol; 2019 Jul; 19(1):143. PubMed ID: 31299890
[TBL] [Abstract][Full Text] [Related]
3. Generation of an ELTD1 knockout human embryonic stem cell line by the iCRISPR/Cas9 system.
Luo Q; Wei C; Long Y; Zhang M; Shan W; Li H; Cai S; Xu Y; Qian P; Huang H
Stem Cell Res; 2021 May; 53():102350. PubMed ID: 34087984
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker.
Serban F; Artene SA; Georgescu AM; Purcaru SO; Tache DE; Alexandru O; Dricu A
Onco Targets Ther; 2015; 8():3767-74. PubMed ID: 26719704
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of the adhesion GPCR ADGRL4/ELTD1 promotes endothelial sprouting angiogenesis without activating canonical GPCR signalling.
Favara DM; Liebscher I; Jazayeri A; Nambiar M; Sheldon H; Banham AH; Harris AL
Sci Rep; 2021 Apr; 11(1):8870. PubMed ID: 33893326
[TBL] [Abstract][Full Text] [Related]
6. ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.
Ziegler J; Pody R; Coutinho de Souza P; Evans B; Saunders D; Smith N; Mallory S; Njoku C; Dong Y; Chen H; Dong J; Lerner M; Mian O; Tummala S; Battiste J; Fung KM; Wren JD; Towner RA
Neuro Oncol; 2017 Feb; 19(2):175-185. PubMed ID: 27416955
[TBL] [Abstract][Full Text] [Related]
7. ELTD1-An Emerging Silent Actor in Cancer Drama Play.
Sevastre AS; Buzatu IM; Baloi C; Oprita A; Dragoi A; Tataranu LG; Alexandru O; Tudorache S; Dricu A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068040
[TBL] [Abstract][Full Text] [Related]
8. ADGRL4/ELTD1 Silencing in Endothelial Cells Induces ACLY and SLC25A1 and Alters the Cellular Metabolic Profile.
Favara DM; Zois CE; Haider S; Pires E; Sheldon H; McCullagh J; Banham AH; Harris AL
Metabolites; 2019 Nov; 9(12):. PubMed ID: 31775252
[TBL] [Abstract][Full Text] [Related]
9. ELTD1 Review: New Regulator of Angiogenesis in Glioma.
Buzatu I; Tache DE; Manea Carneluti EV; Zlatian O
Curr Health Sci J; 2023; 49(4):495-502. PubMed ID: 38559823
[TBL] [Abstract][Full Text] [Related]
10. Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma.
Serban F; Daianu O; Tataranu LG; Artene SA; Emami G; Georgescu AM; Alexandru O; Purcaru SO; Tache DE; Danciulescu MM; Sfredel V; Dricu A
J Immunoassay Immunochem; 2017; 38(1):21-33. PubMed ID: 27379831
[TBL] [Abstract][Full Text] [Related]
11. ELTD1, a potential new biomarker for gliomas.
Towner RA; Jensen RL; Colman H; Vaillant B; Smith N; Casteel R; Saunders D; Gillespie DL; Silasi-Mansat R; Lupu F; Giles CB; Wren JD
Neurosurgery; 2013 Jan; 72(1):77-90; discussion 91. PubMed ID: 23096411
[TBL] [Abstract][Full Text] [Related]
12. ELTD1 Function in Hepatocellular Carcinoma is Carcinoma-Associated Fibroblast-Dependent.
Kan A; Le Y; Zhang YF; Duan FT; Zhong XP; Lu LH; Ling YH; Guo RP
J Cancer; 2018; 9(14):2415-2427. PubMed ID: 30026838
[No Abstract] [Full Text] [Related]
13. ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype.
Sheldon H; Alexander J; Bridges E; Moreira L; Reilly S; Ang KH; Wang D; Lin S; Haider S; Banham AH; Harris AL
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681953
[TBL] [Abstract][Full Text] [Related]
14. A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.
Masiero M; Simões FC; Han HD; Snell C; Peterkin T; Bridges E; Mangala LS; Wu SY; Pradeep S; Li D; Han C; Dalton H; Lopez-Berestein G; Tuynman JB; Mortensen N; Li JL; Patient R; Sood AK; Banham AH; Harris AL; Buffa FM
Cancer Cell; 2013 Aug; 24(2):229-41. PubMed ID: 23871637
[TBL] [Abstract][Full Text] [Related]
15. ELTD1 is present in extracellular vesicles derived from endothelial cells as a cleaved extracellular domain which induces in vivo angiogenesis.
Sheldon H; Zhang W; Bridges E; Ang KH; Lin S; Masiero M; Li D; Handford PA; Whiteman P; Fischer R; Buffa F; Vatish M; Banham AH; Harris AL
J Extracell Biol; 2022 Aug; 1(8):e52. PubMed ID: 38939053
[TBL] [Abstract][Full Text] [Related]
16. Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.
Ziegler J; Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Patel M; Wren JD; Lupu F; Battiste J; Towner RA
Am J Nucl Med Mol Imaging; 2019; 9(1):93-109. PubMed ID: 30911439
[TBL] [Abstract][Full Text] [Related]
17. 7TM Domain Structure of Adhesion GPCRs.
de Graaf C; Nijmeijer S; Wolf S; Ernst OP
Handb Exp Pharmacol; 2016; 234():43-66. PubMed ID: 27832483
[TBL] [Abstract][Full Text] [Related]
18. ELTD1 as a multi-focal target for malignant gliomas: preclinical studies.
Zalles M; Smith N; Saunders D; Guzman M; Lerner M; Fung KM; Babu A; Battiste J; Chung J; Hwang K; Jin J; Towner RA
Neurooncol Adv; 2021; 3(1):vdab132. PubMed ID: 34704036
[TBL] [Abstract][Full Text] [Related]
19. G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.
De Francesco EM; Sotgia F; Clarke RB; Lisanti MP; Maggiolini M
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29240722
[TBL] [Abstract][Full Text] [Related]
20. Remarkable similarities between the hemichordate (Saccoglossus kowalevskii) and vertebrate GPCR repertoire.
Krishnan A; Almén MS; Fredriksson R; Schiöth HB
Gene; 2013 Sep; 526(2):122-33. PubMed ID: 23685280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
